These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31971162)

  • 1. Antimicrobial Resistance in
    Archambault M; Rubin JE
    Microbiol Spectr; 2020 Jan; 8(1):. PubMed ID: 31971162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and antimicrobial susceptibility of obligate anaerobic bacteria from clinical samples of animal origin.
    Mayorga M; Rodríguez-Cavallini E; López-Ureña D; Barquero-Calvo E; Quesada-Gómez C
    Anaerobe; 2015 Dec; 36():19-24. PubMed ID: 26385434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.
    Hastey CJ; Boyd H; Schuetz AN; Anderson K; Citron DM; Dzink-Fox J; Hackel M; Hecht DW; Jacobus NV; Jenkins SG; Karlsson M; Knapp CC; Koeth LM; Wexler H; Roe-Carpenter DE;
    Anaerobe; 2016 Dec; 42():27-30. PubMed ID: 27427465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.
    Tyrrell KL; Citron DM; Merriam CV; Leoncio E; Goldstein EJC
    Anaerobe; 2018 Dec; 54():39-41. PubMed ID: 30096588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
    Jamal W; Shahin M; Rotimi VO
    Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different breakpoints interpretation yielded distinct resistance rates to moxifloxacin of clinically significant anaerobic bacteria.
    Cobo F; Sadyrbaeva-Dolgova S; Navarro-Marí JM
    Anaerobe; 2021 Dec; 72():102471. PubMed ID: 34715325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic resistance: should we be worried?
    Cooley L; Teng J
    Curr Opin Infect Dis; 2019 Dec; 32(6):523-530. PubMed ID: 31567734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
    Finegold SM; Bolanos M; Sumannen PH; Molitoris DR
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3996-4001. PubMed ID: 19581457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility patterns of anaerobic bacteria identified from clinical specimens of diseased dogs and cats.
    Tsuyuki Y; Nakazawa S; Kubo S; Goto M; Takahashi T
    J Vet Med Sci; 2020 Oct; 82(9):1316-1320. PubMed ID: 32713891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and clinical findings of significant anaerobic bacteria in southern Spain.
    Cobo F; Rodríguez-Granger J; Pérez-Zapata I; Sampedro A; Aliaga L; Navarro-Marí JM
    Anaerobe; 2019 Oct; 59():49-53. PubMed ID: 31103531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in Clostridioides difficile.
    O'Grady K; Knight DR; Riley TV
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of porcine Brachyspira hyodysenteriae and Brachyspira pilosicoli isolated in Sweden between 1990 and 2010.
    Pringle M; Landén A; Unnerstad HE; Molander B; Bengtsson B
    Acta Vet Scand; 2012 Sep; 54(1):54. PubMed ID: 22998753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria.
    Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2493-503. PubMed ID: 22290948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis for antibiotic resistance in anaerobes.
    Sebald M
    Clin Infect Dis; 1994 May; 18 Suppl 4():S297-304. PubMed ID: 8086579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
    Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: A prospective multicenter surveillance study in Japan.
    Yunoki T; Matsumura Y; Yamamoto M; Tanaka M; Hamano K; Nakano S; Noguchi T; Nagao M; Ichiyama S;
    Anaerobe; 2017 Dec; 48():215-223. PubMed ID: 28935196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Susceptibility Patterns of Brachyspira Species Isolated in Taiwan.
    Yeh JC; Lo DY; Chang SK; Kuo HC
    Microb Drug Resist; 2018 Jun; 24(5):685-692. PubMed ID: 29653474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.